Biolase Analyst Ratings
Biolase Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/20/2023 | 183.02% | Lake Street | → $1.5 | Assumes | → Buy |
| 05/20/2022 | 2164.15% | Lake Street | → $12 | Initiates Coverage On | → Buy |
| 10/14/2020 | 88.68% | Maxim Group | → $1 | Initiates Coverage On | → Buy |
| 06/19/2019 | 277.36% | Benchmark | → $2 | Initiates Coverage On | → Speculative Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 01/20/2023 | 183.02% | 湖街 | → 1.5 美元 | 假设 | → 购买 |
| 05/20/2022 | 2164.15% | 湖街 | → 12 美元 | 启动覆盖范围开启 | → 购买 |
| 2020 年 10 月 14 日 | 88.68% | Maxim 集团 | → 1 美元 | 启动覆盖范围开启 | → 购买 |
| 06/19/2019 | 277.36% | 基准 | → 2 美元 | 启动覆盖范围开启 | → 投机性买入 |
What is the target price for Biolase (BIOL)?
生物酶（BIOL）的目标价格是多少？
The latest price target for Biolase (NASDAQ: BIOL) was reported by Lake Street on January 20, 2023. The analyst firm set a price target for $1.50 expecting BIOL to rise to within 12 months (a possible 183.02% upside). 2 analyst firms have reported ratings in the last year.
Lake Street于2023年1月20日公布了Biolase（纳斯达克股票代码：BIOL）的最新目标股价。该分析公司将目标股价定为1.50美元，预计BIOL将在12个月内升至12个月内（可能上涨183.02％）。去年有2家分析公司公布了评级。
What is the most recent analyst rating for Biolase (BIOL)?
分析师对Biolase（BIOL）的最新评级是多少？
The latest analyst rating for Biolase (NASDAQ: BIOL) was provided by Lake Street, and Biolase their buy rating.
Lake Street提供了Biolase（纳斯达克股票代码：BIOL）的最新分析师评级，而Biolase则提供了买入评级。
When is the next analyst rating going to be posted or updated for Biolase (BIOL)?
Biolase（BIOL）的下一次分析师评级何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biolase, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biolase was filed on January 20, 2023 so you should expect the next rating to be made available sometime around January 20, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Biolase的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Biolase的最新评级是在2023年1月20日发布的，因此您应该预计下一个评级将在2024年1月20日左右公布。
Is the Analyst Rating Biolase (BIOL) correct?
分析师评级生物酶（BIOL）是否正确？
While ratings are subjective and will change, the latest Biolase (BIOL) rating was a with a price target of $0.00 to $1.50. The current price Biolase (BIOL) is trading at is $0.53, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Biolase（BIOL）评级为0.00美元至1.50美元。Biolase（BIOL）目前的交易价格为0.53美元，在分析师的预测区间内。